Review of Synthetic Routes and Crystalline Forms of the Oncology Drugs Capmatinib, Selpercatinib, and Pralsetinib-Reference-Cited by-同舟云学术

Review of Synthetic Routes and Crystalline Forms of the Oncology Drugs Capmatinib, Selpercatinib, and Pralsetinib

Published:2021-09-17 Issue:10 Volume:25 Page:2192-2204
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Hughes David L.¹^ORCID

Affiliation:

1. Cidara Therapeutics6755 Mira Mesa Boulevard, Suite 123-217, San Diego, California 92121, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.1c00282

Reference38 articles.

1. https://www.cato-sms.com/ema-fda-approvals-and-recommendations-in-2020-for-oncology-drugs-and-diagnostics-devices/ (accessed 2021-07-11).

2. Capmatinib: First Approval

3. https://pubchem.ncbi.nlm.nih.gov/compound/Capmatinib (accessed 2021-07-11).

4. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213591Orig1s000ChemR.pdf (accessed 2021-07-11).

5. Zhuo, J.; Xu, M.; He, C.; Zhang, C.; Qian, D.Q.; Metcalf, B.; Yao, W. Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors. U.S. Patent 7,767,675 B2, August 3, 2010.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pd-Catalyzed Borylation in Water and Its Application to the Synthesis of Active Pharmaceutical Ingredient (API) Intermediates;The Journal of Organic Chemistry;2024-08-20

2. An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021);Anti-Cancer Agents in Medicinal Chemistry;2024-05

3. Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022;Results in Chemistry;2024-01

4. Perfluoro‐tert‐butyl Group‐Derived Capmatinib: Synthesis, Biological Evaluation and Its Application in ¹⁹F Magnetic Resonance Imaging;ChemBioChem;2023-08-16